Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
47309-59-1
Molecular formula
C22H40N+
Molecular weight
318.6 g/mol
Drug class
Quaternary ammonium antiseptic and preservativecationic surfactant
Mechanism of action
Disrupts microbial cell membranes through adsorption to negatively charged membrane components, increasing permeability and causing leakage of cellular contents. Activity depends on chain length, concentration and organism.
Indications / reported uses
Topical antiseptic use in selected skin preparations and disinfectant formulations
Preservative in certain ophthalmic, nasal and other topical products; preservative use should not be mistaken for an active therapeutic indication
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Benzalkonium PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Benzalkonium Permitted Daily Exposure (PDE) report (the Benzalkonium PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Benzalkonium Occupational Exposure Limit (OEL) report (the Benzalkonium OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.